IBDEI0YH ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,34699,1,4,0)
 ;;=4^M05.161
 ;;^UTILITY(U,$J,358.3,34699,2)
 ;;=^5009878
 ;;^UTILITY(U,$J,358.3,34700,0)
 ;;=M05.111^^125^1642^39
 ;;^UTILITY(U,$J,358.3,34700,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34700,1,3,0)
 ;;=3^Rheu Lung Disease w/ Rheu Arth of Right Shldr
 ;;^UTILITY(U,$J,358.3,34700,1,4,0)
 ;;=4^M05.111
 ;;^UTILITY(U,$J,358.3,34700,2)
 ;;=^5009863
 ;;^UTILITY(U,$J,358.3,34701,0)
 ;;=M05.131^^125^1642^40
 ;;^UTILITY(U,$J,358.3,34701,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34701,1,3,0)
 ;;=3^Rheu Lung Disease w/ Rheu Arth of Right Wrist
 ;;^UTILITY(U,$J,358.3,34701,1,4,0)
 ;;=4^M05.131
 ;;^UTILITY(U,$J,358.3,34701,2)
 ;;=^5009869
 ;;^UTILITY(U,$J,358.3,34702,0)
 ;;=M05.10^^125^1642^41
 ;;^UTILITY(U,$J,358.3,34702,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34702,1,3,0)
 ;;=3^Rheu Lung Disease w/ Rheu Arth of Unspec Site
 ;;^UTILITY(U,$J,358.3,34702,1,4,0)
 ;;=4^M05.10
 ;;^UTILITY(U,$J,358.3,34702,2)
 ;;=^5009862
 ;;^UTILITY(U,$J,358.3,34703,0)
 ;;=D86.86^^125^1642^42
 ;;^UTILITY(U,$J,358.3,34703,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34703,1,3,0)
 ;;=3^Sarcoid Arthropathy
 ;;^UTILITY(U,$J,358.3,34703,1,4,0)
 ;;=4^D86.86
 ;;^UTILITY(U,$J,358.3,34703,2)
 ;;=^5002451
 ;;^UTILITY(U,$J,358.3,34704,0)
 ;;=D86.83^^125^1642^43
 ;;^UTILITY(U,$J,358.3,34704,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34704,1,3,0)
 ;;=3^Sarcoid Iridocyclitis
 ;;^UTILITY(U,$J,358.3,34704,1,4,0)
 ;;=4^D86.83
 ;;^UTILITY(U,$J,358.3,34704,2)
 ;;=^5002448
 ;;^UTILITY(U,$J,358.3,34705,0)
 ;;=D86.81^^125^1642^44
 ;;^UTILITY(U,$J,358.3,34705,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34705,1,3,0)
 ;;=3^Sarcoid Meningitis
 ;;^UTILITY(U,$J,358.3,34705,1,4,0)
 ;;=4^D86.81
 ;;^UTILITY(U,$J,358.3,34705,2)
 ;;=^5002446
 ;;^UTILITY(U,$J,358.3,34706,0)
 ;;=D86.85^^125^1642^45
 ;;^UTILITY(U,$J,358.3,34706,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34706,1,3,0)
 ;;=3^Sarcoid Myocarditis
 ;;^UTILITY(U,$J,358.3,34706,1,4,0)
 ;;=4^D86.85
 ;;^UTILITY(U,$J,358.3,34706,2)
 ;;=^5002450
 ;;^UTILITY(U,$J,358.3,34707,0)
 ;;=D86.87^^125^1642^46
 ;;^UTILITY(U,$J,358.3,34707,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34707,1,3,0)
 ;;=3^Sarcoid Myositis
 ;;^UTILITY(U,$J,358.3,34707,1,4,0)
 ;;=4^D86.87
 ;;^UTILITY(U,$J,358.3,34707,2)
 ;;=^5002452
 ;;^UTILITY(U,$J,358.3,34708,0)
 ;;=D86.84^^125^1642^47
 ;;^UTILITY(U,$J,358.3,34708,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34708,1,3,0)
 ;;=3^Sarcoid Pyelonephritis
 ;;^UTILITY(U,$J,358.3,34708,1,4,0)
 ;;=4^D86.84
 ;;^UTILITY(U,$J,358.3,34708,2)
 ;;=^5002449
 ;;^UTILITY(U,$J,358.3,34709,0)
 ;;=D86.0^^125^1642^48
 ;;^UTILITY(U,$J,358.3,34709,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34709,1,3,0)
 ;;=3^Sarcoidosis of Lung
 ;;^UTILITY(U,$J,358.3,34709,1,4,0)
 ;;=4^D86.0
 ;;^UTILITY(U,$J,358.3,34709,2)
 ;;=^5002442
 ;;^UTILITY(U,$J,358.3,34710,0)
 ;;=D86.2^^125^1642^49
 ;;^UTILITY(U,$J,358.3,34710,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34710,1,3,0)
 ;;=3^Sarcoidosis of Lung w/ Sarcoidosis of Lymph Nodes
 ;;^UTILITY(U,$J,358.3,34710,1,4,0)
 ;;=4^D86.2
 ;;^UTILITY(U,$J,358.3,34710,2)
 ;;=^5002444
 ;;^UTILITY(U,$J,358.3,34711,0)
 ;;=D86.1^^125^1642^50
 ;;^UTILITY(U,$J,358.3,34711,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34711,1,3,0)
 ;;=3^Sarcoidosis of Lymph Nodes
 ;;^UTILITY(U,$J,358.3,34711,1,4,0)
 ;;=4^D86.1
 ;;^UTILITY(U,$J,358.3,34711,2)
 ;;=^5002443
 ;;^UTILITY(U,$J,358.3,34712,0)
 ;;=D86.89^^125^1642^51
 ;;^UTILITY(U,$J,358.3,34712,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34712,1,3,0)
 ;;=3^Sarcoidosis of Oth Sites
 ;;^UTILITY(U,$J,358.3,34712,1,4,0)
 ;;=4^D86.89
 ;;^UTILITY(U,$J,358.3,34712,2)
 ;;=^5002453
 ;;^UTILITY(U,$J,358.3,34713,0)
 ;;=D86.3^^125^1642^52
 ;;^UTILITY(U,$J,358.3,34713,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34713,1,3,0)
 ;;=3^Sarcoidosis of Skin
 ;;^UTILITY(U,$J,358.3,34713,1,4,0)
 ;;=4^D86.3
 ;;^UTILITY(U,$J,358.3,34713,2)
 ;;=^5002445
 ;;^UTILITY(U,$J,358.3,34714,0)
 ;;=D86.9^^125^1642^53
 ;;^UTILITY(U,$J,358.3,34714,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34714,1,3,0)
 ;;=3^Sarcoidosis,Unspec
 ;;^UTILITY(U,$J,358.3,34714,1,4,0)
 ;;=4^D86.9
 ;;^UTILITY(U,$J,358.3,34714,2)
 ;;=^5002454
 ;;^UTILITY(U,$J,358.3,34715,0)
 ;;=M35.01^^125^1642^54
 ;;^UTILITY(U,$J,358.3,34715,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34715,1,3,0)
 ;;=3^Sicca Syndrome w/ Keratoconjunctivitis
 ;;^UTILITY(U,$J,358.3,34715,1,4,0)
 ;;=4^M35.01
 ;;^UTILITY(U,$J,358.3,34715,2)
 ;;=^5011787
 ;;^UTILITY(U,$J,358.3,34716,0)
 ;;=M35.02^^125^1642^55
 ;;^UTILITY(U,$J,358.3,34716,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34716,1,3,0)
 ;;=3^Sicca Syndrome w/ Lung Involvement
 ;;^UTILITY(U,$J,358.3,34716,1,4,0)
 ;;=4^M35.02
 ;;^UTILITY(U,$J,358.3,34716,2)
 ;;=^5011788
 ;;^UTILITY(U,$J,358.3,34717,0)
 ;;=M35.03^^125^1642^56
 ;;^UTILITY(U,$J,358.3,34717,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34717,1,3,0)
 ;;=3^Sicca Syndrome w/ Myopathy
 ;;^UTILITY(U,$J,358.3,34717,1,4,0)
 ;;=4^M35.03
 ;;^UTILITY(U,$J,358.3,34717,2)
 ;;=^5011789
 ;;^UTILITY(U,$J,358.3,34718,0)
 ;;=M35.09^^125^1642^57
 ;;^UTILITY(U,$J,358.3,34718,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34718,1,3,0)
 ;;=3^Sicca Syndrome w/ Oth Organ Involvement
 ;;^UTILITY(U,$J,358.3,34718,1,4,0)
 ;;=4^M35.09
 ;;^UTILITY(U,$J,358.3,34718,2)
 ;;=^5011791
 ;;^UTILITY(U,$J,358.3,34719,0)
 ;;=M35.04^^125^1642^58
 ;;^UTILITY(U,$J,358.3,34719,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34719,1,3,0)
 ;;=3^Sicca Syndrome w/ Tubulo-Interstitial Nephropathy
 ;;^UTILITY(U,$J,358.3,34719,1,4,0)
 ;;=4^M35.04
 ;;^UTILITY(U,$J,358.3,34719,2)
 ;;=^5011790
 ;;^UTILITY(U,$J,358.3,34720,0)
 ;;=M35.00^^125^1642^59
 ;;^UTILITY(U,$J,358.3,34720,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34720,1,3,0)
 ;;=3^Sicca Syndrome,Unspec
 ;;^UTILITY(U,$J,358.3,34720,1,4,0)
 ;;=4^M35.00
 ;;^UTILITY(U,$J,358.3,34720,2)
 ;;=^5011786
 ;;^UTILITY(U,$J,358.3,34721,0)
 ;;=M32.10^^125^1642^62
 ;;^UTILITY(U,$J,358.3,34721,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34721,1,3,0)
 ;;=3^Systemic Lupus Erythematosus,Unspec Organ/System Involvement
 ;;^UTILITY(U,$J,358.3,34721,1,4,0)
 ;;=4^M32.10
 ;;^UTILITY(U,$J,358.3,34721,2)
 ;;=^5011753
 ;;^UTILITY(U,$J,358.3,34722,0)
 ;;=M32.9^^125^1642^61
 ;;^UTILITY(U,$J,358.3,34722,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34722,1,3,0)
 ;;=3^Systemic Lupus Erythematosus,Unspec
 ;;^UTILITY(U,$J,358.3,34722,1,4,0)
 ;;=4^M32.9
 ;;^UTILITY(U,$J,358.3,34722,2)
 ;;=^5011761
 ;;^UTILITY(U,$J,358.3,34723,0)
 ;;=M34.2^^125^1642^63
 ;;^UTILITY(U,$J,358.3,34723,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34723,1,3,0)
 ;;=3^Systemic Sclerosis Induced by Drug/Chemical
 ;;^UTILITY(U,$J,358.3,34723,1,4,0)
 ;;=4^M34.2
 ;;^UTILITY(U,$J,358.3,34723,2)
 ;;=^5011780
 ;;^UTILITY(U,$J,358.3,34724,0)
 ;;=M34.81^^125^1642^64
 ;;^UTILITY(U,$J,358.3,34724,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34724,1,3,0)
 ;;=3^Systemic Sclerosis w/ Lung Involvement
 ;;^UTILITY(U,$J,358.3,34724,1,4,0)
 ;;=4^M34.81
 ;;^UTILITY(U,$J,358.3,34724,2)
 ;;=^5011781
 ;;^UTILITY(U,$J,358.3,34725,0)
 ;;=M34.82^^125^1642^65
 ;;^UTILITY(U,$J,358.3,34725,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34725,1,3,0)
 ;;=3^Systemic Sclerosis w/ Myopathy
 ;;^UTILITY(U,$J,358.3,34725,1,4,0)
 ;;=4^M34.82
 ;;^UTILITY(U,$J,358.3,34725,2)
 ;;=^5011782
 ;;^UTILITY(U,$J,358.3,34726,0)
 ;;=M34.83^^125^1642^66
 ;;^UTILITY(U,$J,358.3,34726,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34726,1,3,0)
 ;;=3^Systemic Sclerosis w/ Polyneuropathy
 ;;^UTILITY(U,$J,358.3,34726,1,4,0)
 ;;=4^M34.83
 ;;^UTILITY(U,$J,358.3,34726,2)
 ;;=^5011783
 ;;^UTILITY(U,$J,358.3,34727,0)
 ;;=M34.9^^125^1642^67
 ;;^UTILITY(U,$J,358.3,34727,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34727,1,3,0)
 ;;=3^Systemic Sclerosis,Unspec
